|
Jul 2
|
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
|
|
Jun 26
|
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
|
|
May 22
|
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
|
|
Apr 17
|
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
|
|
Apr 16
|
Biomerica Announces Reverse Stock Split
|
|
Apr 15
|
Biomerica Reports Third Quarter Fiscal 2025 Financial Results
|
|
Feb 27
|
Biomerica’s tests for IBD conditions gain CE-marking under EU’s IVDR
|
|
Feb 26
|
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
|
|
Feb 19
|
February 2025's Top US Penny Stocks To Consider
|
|
Feb 19
|
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
|
|
Sep 4
|
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer
|
|
Aug 31
|
Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023)
|
|
Aug 29
|
Biomerica Reports Fiscal 2024 Year End Results
|
|
May 13
|
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
|
|
Apr 29
|
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
|
|
Apr 15
|
Biomerica provides update on inFoods® IBS expansion
|
|
Apr 12
|
Biomerica Reports Third Quarter 2024 Financial Results
|
|
Mar 28
|
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
|
|
Jan 16
|
Biomerica Reports Second Quarter 2024 Financial Results
|
|
Dec 20
|
Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?
|